Studies have shown that active fund managers routinely underperform the S&P500 index*​

Celularity Inc. (NASDAQ: CELU)

CELU Stock Predictions and Ratings

WSX Rating:
SELL
WSX Forecast (1yr):
-5%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
194.10%

CELU Stock Analysis

CELU PE Ratio:

CELU PEG Ratio: Not Available

CELU Forward EPS Growth (12 month): 0.00%

CELU PS Ratio: 0.9

CELU PSG Ratio: Not Available

CELU Forward Revenue Growth (12 month): 0.00%

CELU Articles

No data was found